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ABSTRACT
Background. We evaluated the heterogeneity of primary
tumor volume (PTV) within tumors of the same pT4a-
staged tongue carcinoma and to elucidate the effects of
PTV on treatment outcomes in patients with pT4a-staged
tongue carcinoma.
Methods. Fifty-eight patients with newly diagnosed pT4a-
staged tongue carcinoma who received surgery were
enrolled onto this study. Magnetic resonance imaging–
derived PTV was measured by the summation-of-area
technique.
Results. The mean PTV was 24.55 ml, with a range of
5.32 to 119.64 ml. The receiver operating characteristic
curve was applied, and the optimal cutoff volume was
23 ml. Large PTV was associated with a signiﬁcantly poor
disease-speciﬁc survival (P = 0.010) by the log rank test.
The Cox regression model also revealed that large PTV
(P = 0.026) and positive lymphatic node metastasis
(P = 0.004) were statistically signiﬁcant in the prognosis
of T4a-staged tongue carcinoma.
Conclusions. A substantial variation of PTV was present
within the same pT4a-staged tongue carcinoma, and PTV
represented an important prognostic factor. In the light of
these ﬁndings, we suggest that taking the PTV into account
in pT4a-staged tongue carcinoma would better reﬁne the
newest revised T classiﬁcation, and the treatment strategies
may be different.
Oral cancer is preponderant in Taiwan, with annual inci-
denceratesof37per100,000formen.Italsoisrankedasthe
fourthleadingcauseofcancerdeathamongmenaccordingto
a 2005 cancer registry report.
1 Regarding anatomic sites,
tongue cancer is most common in Taiwan. As is the case for
other malignancies, the staging system keeps changing and
the identiﬁcation of risk factors continues to develop for
predictingtheprognosisofpatientsandselectingappropriate
treatment modalities. The most widely used system is the
American joint Committee of Cancer (AJCC) staging sys-
tem.
2 Compared with other subsites of oral cancers, tongue
cancer has some unique characteristics, as follows. The
tongueconsistsofintrinsicandextrinsicmuscularstructures,
sothereisnostrongbarriertostopthetumorfromspreading.
Inaddition,whencomparedtootherheadandneckanatomic
site, the vascular and lymphatic systems of tongue are well
developed, and thus the rate of cervical lymph node metas-
tasisishigh.
3Becauseoftheuniqueanatomicstructureofthe
tongue, there is much debate about the conventional T-stage
classiﬁcation that considers lesion size only. Since 1997, the
AJCC has revised the T classiﬁcation by incorporating
extrinsic muscle invasion.
2 However, the debates continue;
for example, some authors have suggested that the depth of
invasion was associated with neck metastasis and affected
nodalupstagingintonguecancerorheadandneckcancer.
4–6
Studies have shown that tumor volumes predicted local
control of head and neck cancers. Large tumors were more
likely to recur than small tumors in the same location.
Part of this study was presented at the Second World Congress of the
International Academic of Oral Oncology 8–11 July 2009, Toronto,
Canada.
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7–9 In
nasopharyngeal carcinoma, the impact of primary tumor
volume has been well established by our team.
10–15 To our
knowledge, for the head and neck region, no literature has
been published about the primary tumor volume for tongue
cancer. Although such disease is resectable, clinicians
commonly agree that the prognosis is poor in pT4a-staged
tongue carcinoma, despite currently aggressive treatment.
However, to our knowledge, the relationship between pri-
mary tumor volume and treatment outcome within the
same pT4a-staged tongue carcinoma, which has the poorest
prognosis, has never been studied.
The aims of this study were to evaluate the variability of
primary tumor volume within the pT4a-staged tongue car-
cinomaandtoelucidatetheimpactofprimarytumorvolume
on the prognosis of patients with pT4a-staged tongue carci-
noma after surgery and adjuvant therapy. The results may
provide empiric evidence for reﬁning both the tumor, node,
metastasis system staging system and the clinical manage-
ment of patients with pT4a-staged oral tongue carcinoma.
PATIENTS AND METHODS
Patient Selection
A sequential and prospectively maintained head and neck
cancer database was retrospectively searched for newly
diagnosed tongue carcinoma treated with surgery between
2003 and 2006. An institutional review board approved this
study. During this 4-year period, 169 patients with newly
diagnosed tongue cancer treated in our tertiary referral med-
ical center and 153 patients (90.5%) who underwent surgery
with or without adjuvant chemoradiotherapy had complete
data available for analysis. The inclusion criteria were as
follows: primary oral tongue cancer; pathologically proven
T4a(pT4a)-staged squamous cell carcinoma with preopera-
tive magnetic resonance imaging (MRI); and accepted
primary tumor wide excision with neck dissection in our
medical center with deﬁnitely pathologic T and N classiﬁca-
tion. The exclusion criteria were as follows: presence of
distant metastasis at the time of presentation (3 patients);
artifacts on MRI that resulted in difﬁculty with delineating
tumor contours (1 patient); and loss to follow-up (1 patient).
Fifty-eight patients were eligible for analysis; 49 received
postoperative radiotherapy and 32 received adjuvant chemo-
therapy. The end of follow-up was November 30, 2009.
Tumor Volume Measurement
All patients in this study underwent pretreatment MRI.
The MRI was performed on a 1.5-T magnetic resonance
unit (Magnetom Avanto, Siemens Medical Solution,
Erlangen, Germany). Sequences included axial T1-weigh-
ted images (TR/TE/NEX, 450/20/3; matrix size, 320 9 80;
section thickness, 4 mm), axial T2-weighted images (TR/
TE/NEX, 4520/76/3; matrix size, 384 9 80; section
thickness, 4 mm), axial fat-suppressed T2-weighted
sequence (repetition time [TR]/echo time [TE], 5080 ms/
82 ms; section thickness, 6 mm; matrix size, 320 9 80),
coronal fat-suppressed T2-weighted sequence (TR/TE,
4000 ms/100 ms; section thickness, 4 mm; matrix size,
256 9 90) and contrast-enhanced T1-weighted spin-echo
images with the use of a 320 9 80 matrix in the axial
planes and 320 9 80 matrix in coronal and sagittal planes
after a bolus injection of 0.1 mmol/kg gadopentetate
dimeglumine (Schering, Berlin, Germany). The T1-TE-
axial images with contrast and fat suppression were
selected for tumor volume measurements; the other
sequences were taken to provide for auxiliary diagnosis.
With applied software, each image of T1-TE-axial view
with contrast plus fat suppression was visualized on a
large-screen monitor. User-deﬁned magniﬁcation of the
images was possible. For tumor characteristics, clinicians
kept track of the tumor contour manually. The primary
tumor volume was calculated by the summation-of-area
technique, which multiplies the entire areas by the image
reconstruction interval of 4 mm. As was done in our pre-
vious studies and also in a pilot study that focused on 10
patients with tongue cancer, in the current study, one
author (C.M.C.) was the major assessor of tumor volumes
and was assisted by the senior author (M.K.C.).
10–15 Thus
two clinicians read the MRIs and kept track of the tumor
contours, and another author (C.M.C.) then calculated the
tumor volume. A radiologist who specialized in head and
neck malignancies participated when the judgments of the
two authors differed; and the tumor contour was assessed
by consensus. One patient was excluded from this study
because of difﬁculty with delineating tumor contours by
the three clinicians. To reduce bias, assessors of the tumor
volumes were blinded to the patients’ condition.
Statistical Analysis
To segregate the patients into large and small tumor
volume groups, the receiver operating characteristic (ROC)
analysis was applied to determine the optimal cutoff point
value obtained by calculating the sensitivity and speciﬁcity
of every observed data value and plotting sensitivity
against 1 - speciﬁcity. Neck lymph node metastasis,
pathological grade, lymphovascular invasion, perineural
invasion, status of surgical margin, and cross midline
extension were analyzed by univariate analysis. Disease-
speciﬁc survival was the primary outcome variable for this
study. The survival curves were calculated by the Kaplan–
Meier method, and differences were assessed by the log
1448 M.-K. Chen et al.rank test. A Cox proportional hazard regression model also
was applied to access the correlations between primary
tumor volume and neck metastasis (with or without adju-
vant chemotherapy and radiotherapy), and the prognosis of
patients after they received therapy while controlling for
age and sex. A P value of B0.05 was considered to be
statistically signiﬁcant.
RESULTS
A substantial variation in primary tumor volume was
observed within the same T4a-staged disease. The mean
primary tumor volume was 24.55 ml, with a range of 5.32
to 119.64 ml. The ROC curve revealed that the optimal
cutoff volume was 23 ml; the area under the ROC curve
was 68.5% (Fig. 1). Patients were followed from 5 to
80 months, and the mean follow-up time was 28.4 months.
Patient characteristics, neck lymph node status, pathologi-
cal grade, lymphovascular invasion, status of surgical
margin, cross midline extension, follow-up, and the dis-
tribution of primary tumor volume are presented in
Table 1. Only cross midline extension and the mean tumor
volume were statistically associated with larger tumor
volume (P\0.05), whereas sex, age, neck lymph node
status, pathological grade, perineural invasion, lympho-
vascular invasion, and status of surgical margin did not
reach statistical signiﬁcance. However, patients with large
primary tumor volume had higher neck metastasis rate
(68% vs. 44%), although this did not reach the statistical
signiﬁcance (P = 0.08). Figure 2 shows that after segre-
gating the primary tumor volume into two subgroups
(\23 ml and C23 ml), large primary tumor volume
(C23 ml) was associated with a signiﬁcantly poorer dis-
ease-speciﬁc survival (P = 0.010). The 2-year disease-
speciﬁc survival rates were 72% in patients with small
tumor volumes versus 42% in patients with large tumor
volumes within the same pT4a-staged disease. Six patients
had local recurrence, and 5 of them (83.3%) belonged to
the large primary tumor volume. The Cox regression model
revealed that the primary tumor volume (P = 0.026; risk
ratio = 2.68; 95% conﬁdence interval [95% CI],
1.13–6.39) and neck lymph node metastasis (P = 0.003;
risk ratio = 7.13; 95% CI, 1.94–25.18) were statistically
signiﬁcant in the prognosis of pT4a-staged tongue carci-
noma, whereas pathological grade, postoperative
radiotherapy, and postoperative chemotherapy were not
statistically signiﬁcant (Table 2).
DISCUSSION
Accurate disease staging of patients with malignancies
is essential to divide patients into prognostic subgroups, to
allow delivery of stage-speciﬁc therapies, and to facilitate
meaningful discussions between physicians and patients
regarding management and expected outcomes. The AJCC
T classiﬁcation of oral tongue carcinoma is mainly based
on tumor size. In 2002, T classiﬁcation was revised, adding
the presence or absence of extrinsic muscle invasion as
stage T4a.
16 In oral cavity cancer, T4a is deﬁned as tumor
invades adjacent structures (e.g., through cortical bone,
into deep [extrinsic] muscle of tongue [genioglossus,
hyoglossus, palatoglossus, and styloglossus]), maxillary
sinus, and skin of face. In this study, we used this T clas-
siﬁcation and selected the pT4a-staged patients to be our
target population. Figure 1 shows that large primary tumor
volume was associated with a signiﬁcantly poorer disease-
speciﬁc survival within the same pT4a-staged tongue car-
cinoma. This result revealed that taking the primary tumor
volume into account in T4a-staged tongue carcinoma
would better reﬁne the newest revised T classiﬁcation.
To investigate the association between the primary
tumor volume and other factors, including sex, age, neck
lymph node status, pathological grade, cross midline
extension, perineural invasion, lymphovascular invasion,
and status of surgical margin, we performed univariate
analysis (Table 1). The results showed that only cross
midline extension reaches statistical signiﬁcance, while
large tumor volume had the tendency to neck lymph node
metastasis, high pathological grade, and lymphovascular
invasion. Because of our study’s small sample size, we did
not input all variables in the Cox regression model; the
results revealed that primary tumor volume (P = 0.026;
risk ratio = 2.68; 95% CI, 1.13–6.39) and neck lymph
node metastasis (P = 0.003; risk ratio = 7.13; 95% CI,
1.94–25.18) were statistically signiﬁcant in the prognosis
of pT4a-staged tongue carcinoma. Thus, we suggest that
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FIG. 1 Receiver operating characteristic curve for various cutoff
values of tumor volume (area under curve= 68.5%; optimal cutoff
volume= 23 mL)
Tumor Volume of T4a Tongue Carcinoma 1449T4a tongue cancer with large primary tumor volume
(C23 ml) and neck metastasis should be treated more
aggressively.
The result of surgery with postoperative chemoradio-
therapy for advanced tongue carcinoma has improved over
the years; however, it still remains unsatisfactory. In this
study, the prognosis of patients with primary tumor
TABLE 1 Characteristics of
58 patients with T4a-staged
tongue carcinoma
Characteristic Primary tumor volume Total patients P
\23 ml C23 ml
No. of patients 36 22 58
Sex, n (%)
Female 4 (11%) 0 (0%) 4 (7%) 0.2868
Male 32 (89%) 22 (100%) 54 (93%)
Age (y) (mean ± SD) 52.27 ± 12.61 48.04 ± 7.65 50.67 ± 11.12 0.1613
Lymph node, n (%)
Negative 20 (56%) 7 (32%) 27 (47%) 0.0787
Positive 16 (44%) 15 (68%) 31 (53%)
Pathological grade, n (%)
Well 5 (14%) 3 (14%) 8 (14%) 0.8877
Moderate 29 (80%) 17 (77%) 46 (79%)
Poorly 2 (6%) 2 (9%) 4 (7%)
Perineural invasion, n (%)
Negative 19 (53%) 13 (59%) 32 (55%) 0.6390
Positive 17 (47%) 9 (41%) 26 (45%)
Lymphovascular invasion, n (%)
Negative 31 (86%) 17 (77%) 48 (55%) 0.3872
Positive 5 (14%) 5 (23%) 10 (45%)
Cross midline, n (%)
Negative 34 (94%) 6 (27%) 40 (69%) \0.001
Positive 2 (7%) 16 (73%) 18 (31%)
Surgical margin, n (%)
Negative 35 (97%) 22 (100%) 57 (98%) 1.000
Positive 1 (3%) 0 (0%) 1 (2%)
Tumor volume (ml) (mean ± SD) 12.57 ± 5.56 44.14 ± 26.76 24.55 ± 2.84 \0.0001
Follow-up time (mo) (mean ± SD) 31.30 ± 18.41 22.04 ± 14.73 27.79 ± 18.45 0.0632
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FIG. 2 Disease-speciﬁc survival curves of 58 T4a-staged tongue
carcinoma according to large (C23 mL) and small (\23 mL) tumor
volumes. Within the same T4a-satge, large primary tumor volume was
associatedwithasigniﬁcantlypoordiseasespeciﬁcsurvival(P=.0104)
TABLE 2 Cox regression model for prognosis of T4a-staged tongue
carcinoma
Variable RR 95% CI P
Primary tumor volume (ml)
C23 ml vs.\23 ml 2.68 1.13–6.39 0.0261*
Neck node metastasis
Positive vs. negative 6.92 1.86–25.72 0.0039*
Pathological grade 1.25 1.31–5.00 0.7490
Radiotherapy
With vs. without 1.17 0.21–6.85 0.8488
Chemotherapy
With vs. without 1.16 0.25–5.32 0.8521
RR risk ratio for disease-related survival, 95% CI 95% conﬁdence
interval
Adjusted for age and sex
* P\0.05
1450 M.-K. Chen et al.volumes of[23 ml was poor; the 2-year survival rate was
only 42%. We suggest that the new technique of radio-
therapy, the combination of different regimens of
chemotherapy, and the use of targeted chemotherapy or
immunotherapy may be useful for these patients. Also, for
such patients, postoperative swallowing and phonation
function are affected. The conventional wisdom that sur-
gery is the mainstay of treatment should be challenged.
The current study has some limitations. First, although
we did our best to estimate the tumor volume, the obtained
tumor volume is still not the true tumor volume. Some
error in estimating the tumor volume remains. However,
our previous study revealed that if a single trained observer
estimated the tumor volume, the information bias would be
toward the null.
10–15 Thus, in the current study, we delin-
eated the tumor contour by the consensus of two or three
well-trained head and neck oncologists or radiologists, not
independently. However, with the advancement of MRI
and applied software, we believe the tumor volume might
be measured not only manually, but also by well-designed
software in the future; at that future time, we suggest that
two separate clinicians independently review the MRIs, but
not by consensus. In addition, we believe that if there is no
well-trained head and neck oncologist with experience
measuring tumor volume, then the tumor volume mea-
surements should be performed by a radiologist.
10–15
Second, in the Cox regression model, because the radio-
therapy dose is high, we neglected the fact that there was a
relatively narrow range of dose, and we did not investigate
the effect of total radiation dose on treatment outcome,
which may obscure the important dose–response effect
addressed by Willner et al.
17 Thus, the total dose of
radiotherapy still should be emphasized. Third, some
authors have suggested that the depth of invasion was
associated with neck metastasis and affected nodal
upstaging in tongue cancer or head and neck cancer.
4–6 In
this study, we focused on the primary tumor volume only
because we think that the primary tumor volume is three-
dimensional; it should be more meaningful than the con-
ventional measures of tumor length or thickness. Thus, we
did not evaluate the tumor thickness. Last, changes or
revisions of any staging system should ideally be supported
by evidence-based information generated from large
cohorts of patients. Unfortunately, the head and neck
region comprises a variety of anatomic sites, and these
tumors have diverse clinical behavior and outcomes. It is
therefore literally impossible to generate a uniform staging
system that would be relevant for all tumors arising in the
head and neck region. Another effect of this diversity
among head and neck tumors is that patient cohorts
available for outcomes analysis for most sites are limited in
numbers, and on the whole, no level 1 evidence is available
to support important clinical questions.
18 In this study, we
faced the same problem. The study was a retrospective one
that searched a sequential and prospectively maintained
head and neck cancer database with a limited number of
patients. Although the treatment modality should follow
our clinical guidelines, as a result of the patients’ perfor-
mance status or compliance, there was still bias in this
study. Thus, we applied a Cox proportional hazard
regression model to access the correlations between tumor
volume, neck metastasis, presence or absence of chemo-
therapy and radiotherapy, pathological grade, and the
prognosis of patients after they received therapy while
controlling for age and sex. If a large patient cohort is
available for meaningful data analysis, a prospective ran-
domized trial should be started in the future.
To our knowledge, this study is the ﬁrst to describe the
primary tumor volume of oral tongue cancer. Primary
tumor volumes in patients with tongue carcinoma were
heterogeneous within the concurrent pT4a stage. Primary
tumor volume represented an important prognostic factor
for treatment outcome. We suggest that taking the primary
tumor volume into account in pT4a-staged tongue carci-
noma would better reﬁne the newest revised T
classiﬁcation. Patients with large primary tumor (C23 ml)
had poor prognosis and need more aggressive treatment.
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